alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31.1   CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002  I, George P. Christopulos, certify that:  1. I have reviewed this Annual Report on Form 10-KSB of the Registrant;  2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Report;  3. Based on my knowledge, the financial statements, and other financial information included in this Annual Report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this Report;  4. The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the Registrant and we have:  a) designed such disclosure controls and procedures to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Report is being prepared;  b) evaluated the effectiveness of the Registrant's disclosure controls and procedures as of a date within 90 days prior to the filing date of this Report (the "Evaluation Date"); and  c) presented in this Report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;  5. The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation, to the Registrant's auditors and the audit committee of Registrant's board of directors (or persons performing the equivalent function):  a) all significant deficiencies in the design or operation of internal controls which could adversely affect the Registrant's ability to record, process, summarize and report financial data and have identified for the Registrant's auditors any material weaknesses in internal controls; and  b) any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal controls; and  6. The Registrant's other certifying officer and I have indicated in this Annual Report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.  Dated: March 21, 2008 /s/ George P. Christopulos George P. Christopulos,  CEO, President, CFO, and Chairman   Of the Board
II 

112TH CONGRESS 

2D SESSION S. 2500 

To extend the temporary suspension of duty on 3-methyl-4-(2,6,6- 

trimethylcyclohex-2-enyl)but-3-en-2-one(Methylionone). 

IN THE SENATE OF THE UNITED STATES 

APRIL 26, 2012 

Mr. BROWN of Ohio introduced the following bill; which was read twice and 

referred to the Committee on Finance 

A BILL 

To extend the temporary suspension of duty on 3-methyl4-(2,6,6-trimethylcyclohex-2-enyl)but-3-en-2- 

one(Methylionone). 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. 3-METHYL-4-(2,6,6-TRIMETHYLCYCLOHEX-2- 

4 ENYL)BUT-3-EN-2-ONE(METHYLIONONE). 

5 (a) IN GENERAL.—Heading 9902.11.10 of the Har6 monized Tariff Schedule of the United States (relating to 

7 3-methyl-4-(2,6,6-trimethylcyclohex-2-enyl)but-3-en-2- 

8 one(Methylionone)) is amended by striking the date in the 

9 effective period column and inserting ‘‘12/31/2015’’. 


smartinez on DSK6TPTVN1PROD with BILLS
2 

•S 2500 IS

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies with respect to goods entered, or 

3 withdrawn from warehouse for consumption, on or after 

4 the 15th day after the date of the enactment of this Act. 

Æ 


smartinez on DSK6TPTVN1PROD with BILLS
Robert FAICCO and Roganne D. Faicco, Appellants, v. GREEN TREE SERVICING, LLC, Appellee.

No. 4D17-1019

District Court of Appeal of Florida, Fourth District.

[March 15, 2018]

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
#### Gary L. CORUM, Plaintiff-Appellant, v. Jo Anne B. BARNHART, Commissioner of Social Security, Defendant-Appellee.

No. 03-3247.

United States Court of Appeals, Eighth Circuit.

Submitted Feb. 13, 2004.

Decided May 25, 2004.

James H. Green, Kansas City, MO, for Plaintiff-Appellant.

Jerry Lee Short, Kansas City, MO, Frank V. Smith, III, Chief Counsel, Kevin B. Murphy, Kansas City, MO, for Defendant-Appellee.

Before LOKEN, Chief Judge, BOWMAN and WOLLMAN, Circuit Judges.

PER CURIAM.

Gary L. Corum applied for Social Security Disability Insurance benefits and Supplemental Security Income payments, claiming the onset of disability in April 1999 because of the residual effects of testicular cancer and its treatment, pancreatitis, abdominal and testicular pain, vomiting, diarrhea, dizziness, fatigue, and depression. After a hearing, the Commissioner’s administrative law judge (ALJ) denied the application, finding that Corum is a younger individual who suffers from a combination of impairments that are considered severe but do not equal a listed impairment; that he is unable to perform his past relevant work; that his “allegations regarding his limitations are not credible;” and that he has transferable work skills and the residual functional capacity to perform a significant range of light work.

After the Appeals Council denied Co-rum’s request for further administrative review, he commenced this action seeking judicial review of the Commissioner’s final decision. The district court1 granted summary judgment in favor of the Commissioner, concluding that the agency’s final decision is supported by substantial evidence on the administrative record as a whole. Corum appeals, arguing that the ALJ erred in discounting a residual func*76tional capacity assessment by Corum’s treating physician as inconsistent with the physician’s treatment records and the other medical evidence, and that the ALJ erred in discounting Corum’s complaints of disabling pain and fatigue and therefore failed to include all relevant impairments in posing hypothetical questions to the vocational expert who testified at the administrative hearing. The district court’s thorough opinion addressed each of these issues. After thorough review of the record, we affirm for the reasons stated in the district court’s Order dated July 29, 2003. *See*8th Cir. R. 47B.

1

. The HONORABLE NANETTE K. LAUGHREY, United States District Judge for the Western District of Missouri.
Burke L. SILAS, Appellant, v. STATE of Florida, Appellee.

No. 1D17-4344

District Court of Appeal of Florida, First District.

February 22, 2018 Rehearing Denied April 5, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Securities and Exchange Commission

          - [Investment Company Act Release No. 28650A; 812-13538]

      ( print page 17241)    

## Correction

                    In the                     **Federal Register**                     of March 24, 2009, in FR Doc. E9-6391, on page 12407 of volume 74, in the second column, the date should read March 17, 2009.                

Dated: April 8, 2009.

Florence E. Harmon,

Deputy Secretary.

[FR Doc. E9-8427 Filed 4-13-09; 8:45 am]

BILLING CODE 8010-01-P
Exhibit
32.1





CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In
connection with the annual report of Pharma-Bio Serv, Inc. (the “Company”) on
Form 10-K for the fiscal year ended October 31, 2010 as filed with the
Securities and Exchange Commission on the date hereof (the “report”), the
undersigned, Elizabeth Plaza, the Chief Executive Officer of the Company, and
Pedro J Lasanta, Chief Financial Officer of the Company, each certify, pursuant
to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of
2002, that to our knowledge:





1.
            The
      report fully complies with the requirements of Section 13(a) or Section
      15(d) of the Securities Exchange Act of 1934, as amended;
    and


2.
            The information contained in the
      report fairly presents, in all material respects, the financial condition
      and results of operation of the
Company.




Dated:
      January 31, 2011/s/
      Elizabeth Plaza
                    
                    /s/
      Pedro J. LasantaElizabeth
      Plaza
                    
                    Pedro
      J. LasantaChief
      Executive Officer
                    
                    Chief
      Financial Officer(principal
      executive officer)
                    
                    (principal
      financial and accounting
officer)





This
certification accompanies the Form 10-K to which it relates, is not deemed filed
with the Securities and Exchange Commission and is not to be incorporated by
reference to any filing of Pharma-Bio Serv, Inc. under the Securities Act of
1933, as amended, or the Securities Exchange Act of 1934, as amended (whether
made before of after the date of the Form 10-K), irrespective of any general
incorporation language contained in such filing.
Exhibit 99.1

CERTIFICATION PURSUANT TO 

18 U.S.C. SECTION 1350, 

AS ADOPTED PURSUANT TO 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 

In connection with the Quarterly Report of Sierra Health Services, Inc. (the Company) on Form 10-Q for the period ending March 31, 2003 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Anthony M. Marlon, M.D., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: 

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Anthony M. Marlon, M.D.		**		**	

Anthony M. Marlon, M.D.					

Chief Executive Officer

May 9, 2003**	**
exv4w7



 






EXHIBIT 4.7




February 29, 2008




Securities and Exchange Commission

100 F Street, N.W.

Washington, D.C. 20549




Re: Brookfield Homes Corporation




Ladies and Gentlemen:





In accordance with Item 601(b)(4)(iii) of Regulation S-K, Brookfield Homes Corporation (the “Registrant”) has not filed herewith any instrument with respect to long-term debt not being registered where the total number of securities authorized thereunder does not exceed ten percent (10%) of the total assets of the Registrant and its subsidiaries on a consolidated basis. The Registrant hereby agrees t
o furnish a copy of any such agreement to the Securities and Exchange Commission upon request.



Sincerely,




	 	 	 	 	 
	BROOKFIELD HOMES CORPORATION

 	 	 
	/s/ PAUL G. KERRIGAN
 	 	 
	Paul G. Kerrigan 	 	 
	Executive Vice President and Chief Financial Officer
#### Baghbadran Anoshervan RAVANBAKHSH, Petitioner, v. John ASHCROFT, Attorney General, Respondent.

No. 03-70603.

United States Court of Appeals, Ninth Circuit.

*772Submitted May 10, 2004.*

Decided May 19, 2004.

Marjan H. Bahmani, Esq., Law Offices of Marjan H. Bahmani, Encino, CA, for Petitioner.

Regional Counsel, Western Region Immigration & Naturalization Service, Laguna Niguel, CA, District Counsel, Esq., Office of the District Counsel, Department of Homeland Security, Los Angeles, CA, Ronald E. LeFevre, Chief Legal Officer, Office of the District Counsel, Department of Homeland Security, San Francisco, CA, Michael P. Lindemann, Esq., William C. Peachey, U.S. Department of Justice Civil Div./Office of Immigration Lit., Washington, DC, for Respondent.

Before: CANBY, KOZINSKI, and PAEZ, Circuit Judges.

*

 The panel unanimously finds this case suitable for decision without oral argument. *See*Fed. R.App. P. 34(a)(2).

MEMORANDUM **

Bhagbadran Anoshervan Ravanbakhsh, a native and citizen of Iran, petitions for review of the decision of the Board of Immigration Appeals (“BIA”), summarily affirming an immigration judge’s (“IJ”) denial of his application for asylum and withholding of removal. We have jurisdiction pursuant to 8 U.S.C. § 1252. We review an adverse credibility finding for substantial evidence, *Lata v. INS,*204 F.3d 1241, 1245 (9th Cir.2000), and we reverse only if the evidence compels a contrary conclusion, *INS v. Elias-Zacarias,*502 U.S. 478, 483-84, 112 S.Ct. 812, 117 L.Ed.2d 38 (1992). We deny the petition for review.

Ravanbakhsh’s testimony that he wrote a high school essay that led to his arrest by the Iranian government was inconsistent with his assertion in his declaration that his friend wrote the essay. This inconsistency goes to the heart of his claim because this incident formed the basis of his alleged persecution. *See Chebchoub v. INS,*257 F.3d 1038, 1042-43 (9th Cir.2001). Moreover, substantial evidence supports the IJ’s determination that Ravanbakhsh’s testimony lacked specificity. *See Singh-Kaur v. INS,*183 F.3d 1147, 1153 (9th Cir.1999). Accordingly, substantial evidence supports the IJ’s adverse credibility finding. *See Elias-Zacarias,*502 U.S. at 481.

Because Ravanbakhsh did not testify credibly, he did not establish eligibility for asylum. *See Mejia-Paiz v. INS,*111 F.3d 720, 723 (9th Cir.1997). It follows that he failed to establish eligibility for withholding of removal. *See Alvarez-Santos v. INS,*332 F.3d 1245, 1255 (9th Cir.2003).

We do not consider Ravanbakhsh’s Convention Against Torture claim because he failed to exhaust this issue before the BIA. *See Barron v. Ashcroft,*358 F.3d 674, 678 (9th Cir.2004).

Ravanbakhsh’s contention that the BIA’s streamlined decision violates due process is foreclosed by *Falcon Carriche v. Ashcroft,*350 F.3d 845, 850 (9th Cir.2003).

PETITION FOR REVIEW DENIED.

**

 This disposition is not appropriate for publication and may not be cited to or by the courts of this circuit except as provided by Ninth Circuit Rule 36-3.
BEFORE THE

U.S. DEPARTMENT OF TRANSPORTATION

OFFICE OF THE SECRETARY

WASHINGTON, D.C.

Docket

Docket DOT

- OST

- 2013

- 0214

MOTION OF AIR EUROPA LINEAS AEREAS, S.A.U.

TO STRIKE COMMENTS

Communications with respect to thi s document should be sent to:

Aaron A. Goerlich

Garofalo Goerlich Hainbach PC

1200 New Hampshire Avenue NW

Washington, DC 20036

- 6802

Tel (202) 776

- 3974

Fax (202) 776

- 3975

agoerlich@ggh

- airlaw.com

Counsel f or Air Europa Lineas

Aereas, S.A.U.

March 10 , 2014

BENJAMIN EDELMAN,

Third

- Party Complainant

v.

AIR EUROPA LINEAS AEREAS, S.A.U.

, RespondentBEFORE THE

U.S. DEPARTMENT OF TRANSPORTATION

OFFICE OF THE SECRETARY

WASHINGTON, D.C.

Docket

Docket DOT

- OST

- 20 13

- 0214

MOTION OF AIR EUROPA LINEAS AER EAS, S.A.U.

TO STRIKE COMMENTS

Air Europa Líneas Aéreas, S.A.U. , pursuant to Rule 11 of the Rules of Practice,

moves to strike the comments filed in this docket by Mike Borsetti and Edward

Hasbrouck. Neither commenter is a party to this proceeding, and n either has submitted

a motion for leave to file. The comments are not authorized under the Department’s

rules and should be stricken for that reason alone.

Further, even if the comments a re accepted, they add nothing material to the

record. The Hasbrouc k submission is essentially a n argument for regulatory change s

that ha ve not been proposed by the Department or in any rulemaking petition

. The

Borsetti comment is speculative , conclusory, and devoid of new information

.

N ote additionally that Rule 416 of the Rules of Practice does not contemplate

appearances by non

- parties prior to issuance of an Assistant General Counsel decision

BENJAMIN EDELMAN,

Third

- Party Complainant

v.

AIR EUROPA LINEAS AEREAS, S.A.U.

, Respondentunder R ule 406(a). Section 300.5(b) of the Department’s R ules of C onduct, 14 CFR §

300.5(b), states that no person shall di srupt or interfere with the fair and orderly

disposition of a DOT proceeding. In combination

, these rules compel the conclusion

that the unauthorized comments are an attempt to disrupt or interfere with an orderly

disposition of this proceeding.

Both comments should be stricken for the reasons stated above.

Respectfully submitted,

Aaron A. Goerlich

Garofalo Goerlich Hainbach PC

Counsel for Air Europa Lineas

Aereas, S.A.U.C ERTIFICATE OF SERVICE

I certify that on March 10 , 2014 , I served th e foregoing motion by electronic mail

upon :

Mike Borsetti (mike@borsetti.com)

Benjam in Edelman ( ben@benedelman.org )

Edward Hasbrouck ( e dward@hasbrouck.org )

_______________________________ Aaron A. Goerlich
Exhibit 32.1  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Our Glass, Inc. (the "Company") on Form 10-K for the fiscal year ended December 31, 2010 (the Report), I, Cosmo Palmieri, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: 1) The Report fully complies with the requirement of Section 13(a) or 15 (d) of the Securities Exchange Act of 1934; and 2) The information contained in the Report fairly presents, in all material respects, the Company's financial position and results of operations.  Date: February 28, 2011 /s/Cosmo Palmieri     Chief Executive Officer
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2494 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2494

To renew the temporary suspension of duty on 2-oxepanone, polymer with 
      aziridine and tetrahydro-2H-pyran-2-one, dodecanoate ester.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             April 26, 2012

 Mr. Brown of Ohio introduced the following bill; which was read twice 
                and referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
To renew the temporary suspension of duty on 2-oxepanone, polymer with 
      aziridine and tetrahydro-2H-pyran-2-one, dodecanoate ester.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. 2-OXEPANONE, POLYMER WITH AZIRIDINE AND TETRAHYDRO-2H-PYRAN-
              2-ONE, DODECANOATE ESTER.

    (a) In General.--Heading 9902.03.24 of the Harmonized Tariff 
Schedule of the United States (relating to 2-oxepanone, polymer with 
aziridine and tetrahydro-2H-pyran-2-one, dodecanoate ester) is amended 
by striking the date in the effective period column and inserting ``12/
31/2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
Exhibit 32.1

Certification of Chief Executive Officer of  Advance America, Cash Advance Centers, Inc.  Pursuant to 18 U.S.C. Section 1350  (Adopted by Section 906 of the Sarbanes-Oxley
Act of 2002)

In connection with the Annual Report on Form 10-K of Advance America, Cash Advance Centers, Inc. (the "Company") for the year ended
December 31, 2005, as filed with the Securities and Exchange Commission (the "Report"), I, Kenneth E. Compton, President and Chief Executive Officer, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

| |  | /s/KENNETH E. COMPTONKenneth E. Compton President and Chief Executive
Officer
| |  | -----------------------------------------------------------------------------

March 16,
2006

1

---



QuickLinks
Exhibit
32.2



Certification Pursuant to 18 U.S.C. Section
1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002



In connection with the annual report of
China Housing & Land Development, Inc. (the Company), on Form 10-K/A for the period ended December 31, 2012 as filed with the
Securities and Exchange Commission (SEC) on the date hereof (the Report), the undersigned officer of the Company certifies, pursuant
to 18 U.S.C. ss.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:



| | i. | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange
Act of 1934; and
| | -- | ---------------------------------------------------------------------------------------------------------------------

| | ii. | the information contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



A signed original of this written statement
has been provided to the Company and will be retained by the Company and will be furnished to the SEC or our staff upon request.



|/s/ Cangsang Huang                           | 
|-------------------------------------------- | 
|Cangsang Huang                               | 
|Chief Financial Officer                      | 
|(Principal Accounting and Financial Officer) | 
|March 17, 2014                               | 



The foregoing certification is not deemed
filed with the Securities and Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(Exchange Act), and are not to be incorporated by reference into any filing of China Housing & Land Development, Inc. under
the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general
incorporation language in such filing.